ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Adjuvants, Immunologic

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Immunologic Factors ∟ Biological Response Modifiers ∟ Adjuvants, Immunologic 1 coordinate concept ∟ Interferon Inducers X
Broader terms:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Immunologic Factors ∟ Biological Response Modifiers ∟ Adjuvants, Immunologic Biological Response Modifiers > Immunologic Factors > Physiological Effects of Drugs > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) X
Annotation:	DF: ADJUVANTS IMMUNOL X
historyNote*:	65 X
publicMeSHNote*:	65 X
Scope note:	Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1999-01-01X
dateEstablished*:	1965-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	NLMX
Related term:	Adjuvants, Pharmaceutic X
Type:	Concept X
Coordinate terms:	Interferon Inducers X
URI:	X
Labels and equivalent concepts:	Immunologiset adjuvantit (fi) Immunologinen adjuvantti (fi, replaced) Immunmodulerande medel (sv) Adjuvantia, immunologiska (sv, replaced) Immunmodulatorer (sv, replaced) Immunostimulants (en, replaced) Immunopotentiators (en, replaced) Immunological Adjuvant (en, replaced) Adjuvants, Immunological (en, replaced) Immunoactivators (en, replaced) Immunoadjuvants (en, replaced) Immunologic Adjuvants (en, replaced) Adjuvant, Immunologic (en, replaced) X
Share:	X